Institutional Ownership
Gyre Therapeutics Inc
CUSIP 403783103COMGYREQ1 2026
13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
85.4%
Max % of class reported
Institutional Holders
52
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
6 filings · latest Sep 6, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Sep 6, 2024 | Ma Songjiang | 13D | 7.6% | 7.46M | SEC |
| 2 | Sep 6, 2024 | Luo Ying | 13D | 8.5% | 8.46M | SEC |
| 3 | Feb 14, 2024 | Lytton Laurence W | 13G/A | — | — | SEC |
| 4 | Jan 24, 2024 | Gni Group Ltd. | 13D/A | 85.3% | 73.31M | SEC |
| 5 | Nov 27, 2023 | Gni Group Ltd. | 13D/A | 85.4% | 73.31M | SEC |
| 6 | Nov 1, 2023 | Gni Group Ltd. | 13D/A | 85.4% | 73.31M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 758.6K | $5.29M |
| 2 | Geode Capital Management, LLC | 431.4K | $3.01M |
| 3 | State Street Corp | 216.3K | $1.51M |
| 4 | Sbi Securities Co., Ltd. | 170.8K | $1.19M |
| 5 | Charles Schwab Investment Management Inc | 165.2K | $1.15M |
| 6 | Northern Trust Corp | 133.8K | $932.9K |
| 7 | Goldman Sachs Group Inc | 73.1K | $509.7K |
| 8 | Bank Of New York Mellon Corp | 43.1K | $300.7K |
| 9 | Dimensional Fund Advisors LP | 25.3K | $176.1K |
| 10 | Alliancebernstein L.P. | 21.8K | $154.1K |